Company Information
About the Report- Documents
Outstanding Payments (MSME)
Complaints
Directors- Same Address Companies
- Charges
Contact Details- Products & Services
Balance Sheet- Profit & Loss
Fund Raising- Shareholders & Investors
- Board Meetings
- Auditors
ERIS M. J. BIOPHARM PRIVATE LIMITED
CIN: U51397GJ2002PTC112851 As on: 2026-07-13
ERIS M. J. BIOPHARM PRIVATE LIMITED (CIN: U51397GJ2002PTC112851) is a Private company incorporated on 18 Sep 2002. It is classified as Non-government company and is registered at Registrar of Companies, Ahmedabad. Its authorized share capital is Rs. 30000000.00 and its paid up capital is Rs. 2607040.00.
ERIS M. J. BIOPHARM PRIVATE LIMITED's Annual General Meeting (AGM) was last held on 30 Sep 2023. and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2023-03-31.ERIS M. J. BIOPHARM PRIVATE LIMITED's NIC code is 5139 (which is part of its CIN). As per the NIC code, it is inolved in Wholesale of other household goods.
Directors of ERIS M. J. BIOPHARM PRIVATE LIMITED are KAUSHAL KAMLESH SHAH, AMIT INDUBHUSHAN BAKSHI, AKSHAY AMOL SHAH, KRISHNAKUMAR VAIDYANATHAN, and AMOL JASHVANT SHAH.
ERIS M. J. BIOPHARM PRIVATE LIMITED's Corporate Identification Number (CIN) is U51397GJ2002PTC112851 and its registration number is 112851. Users may contact ERIS M. J. BIOPHARM PRIVATE LIMITED on its Email address - [email protected]. Registered address of ERIS M. J. BIOPHARM PRIVATE LIMITED is 201-204, 2nd Floor, Shivarth Ambit, Plot No. 142/2 Ramdas Road, off SBR, Nr.Swati Bungalows , Bodakdev , Ahmedabad, Gujarat, India - 380054.
Current status of ERIS M. J. BIOPHARM PRIVATE LIMITED is - Active.
Basic Information
- CIN
- Name
- Listed on Stock Exchange
- Company Status
- ROC
- Registration Number
- Company Category
- Company Sub Category
- Class of Company
- Date of Incorporation
- Age of Company
- Activity
- Number of Members
Annual Compliance Status
- Date of Last Annual General Meeting
- Date of Last Filed Balance Sheet
Key Numbers
- Authorised Share Capital
- Paid-up Share Capital
- Total Assets
- Revenue
- Profit
- Salaries & Other Employee Benefit Expenses
Want to see how this company compares within its industry or analyse broader market trends?
Explore Prime Research for Industry & Economic InsightsPrevious Names
Previous CINs
ZaubaCorp's company report for ERIS M. J. BIOPHARM includes audited balance sheets, profit & loss statements, charges, director history, shareholding and related-party transactions, compiled from official MCA filings — delivered as PDF and Excel.
Purchase ReportAll companies in India are required to file various documents like financials, loan agreements, list of shareholders, details of directors, details of funding rounds and a lot more. These documents are credible and offer incredible insights about a company. However, understanding a company by viewing its documents is an extremely difficult and time consuming process.
Our reports are designed to save you significant time by surfacing key information easily and structuring it in a way that helps in your research.
Understanding the key findings and information in our reports can be crucial if you're a customer, vendor, investor, partner or even a potential employee of ERIS M. J. BIOPHARM
Purchase full report of ERIS M. J. BIOPHARM
Companies are required to file half yearly returns showing payments due to Micro & Small Enterprises that have been delayed more than 45 days. This information is crucial to understand if ERIS M. J. BIOPHARM pays its vendors promptly. When seen over a period of time, this information could show if the company has slowed down in making payments to its small vendors. This information is available only if the company has filed its half yearly returns with the registrar of companies.
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of investor complaints or serious complaints filed with the registrar of companies. This information can surface potential red flags about a company.
Director Complaints
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other Details |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Directors & Key Managerial Personnel of ERIS M. J. BIOPHARM
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 01229038 | KAUSHAL KAMLESH SHAH | Director | 2017-09-23 |
| 01250925 | AMIT INDUBHUSHAN BAKSHI | Director | 2022-01-12 |
| 08583966 | AKSHAY AMOL SHAH | Director | 2022-01-12 |
| 08976508 | KRISHNAKUMAR VAIDYANATHAN | Director | 2021-12-17 |
| 00171006 | AMOL JASHVANT SHAH | Director | 2022-01-12 |
Past Directors & Key Managerial Personnel of ERIS M. J. BIOPHARM
| DIN | Director Name | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| 00456596 | RAJESH DHURIA | Director | - | 2019-04-06 |
| 00924587 | DARSHAK JITENDRA SHAH | Director | - | 2016-11-23 |
| 01229038 | KAUSHAL KAMLESH SHAH | Additional Director | - | 2017-09-23 |
| 01250925 | AMIT INDUBHUSHAN BAKSHI | Additional Director | - | 2016-12-12 |
| 01487210 | SAMEER ASHOK PAIGANKAR | Director | - | 2016-11-23 |
| 06688639 | SACHIN SHAH | Additional Director | - | 2020-09-28 |
| 06688639 | SACHIN SHAH | Director | - | 2021-12-17 |
| 00925848 | MURALI VENKATA KRISHNA SISTLA | Director | - | 2015-08-05 |
| 01255388 | INDERJEET SINGH NEGI | Additional Director | - | 2017-09-23 |
| 01255388 | INDERJEET SINGH NEGI | Director | - | 2022-01-12 |
| 01301025 | HIMANSHU JAYANTBHAI SHAH | Additional Director | - | 2016-12-12 |
| 08583966 | AKSHAY AMOL SHAH | Additional Director | - | 2022-09-30 |
| 08976508 | KRISHNAKUMAR VAIDYANATHAN | Additional Director | - | 2022-09-30 |
| 07082847 | ANIL KUMAR SHARMA | Director | - | 2016-11-23 |
| 00171006 | AMOL JASHVANT SHAH | Additional Director | - | 2022-09-30 |
| 01229080 | RAJENDRA RAMBHAI PATEL | Additional Director | - | 2017-09-23 |
| 01229080 | RAJENDRA RAMBHAI PATEL | Director | - | 2020-08-06 |
| 02814751 | RAKESH DHURIA | Director | - | 2018-07-31 |
Other Directorships of RAJESH DHURIA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| TRUMPCARD ENTERTAINMENTS AND MULTIMEDIA LLP | AAQ-7885 | Designated Partner | 2019-10-11 | Ongoing |
| EXCLUSIVE UNIQUE FURNITURE AND INTERIORS PRIVATE LIMITED | U52190RJ2012PTC037813 | Director | 2012-02-04 | Ongoing |
| ACUMEDICA LAB SYSTEMS PRIVATE LIMITED | U74120MH2013PTC240805 | Director | - | 2016-12-19 |
| NOVELTY HEALTHSHINE PRIVATE LIMITED | U93090GJ2018PTC121325 | Additional Director | - | 2021-11-29 |
| NOVELTY HEALTHSHINE PRIVATE LIMITED | U93090GJ2018PTC121325 | Director | 2021-11-29 | Ongoing |
Other Directorships of DARSHAK JITENDRA SHAH
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ADROIT BIOMED LIMITED | U22100MH2009PLC197761 | Additional Director | - | 2017-09-30 |
| ADROIT BIOMED LIMITED | U22100MH2009PLC197761 | Director | 2017-09-30 | Ongoing |
| PHARMA-SERV HEALTHCARE PRIVATE LIMITED | U24230MH2004PTC146489 | Director | 2004-05-24 | Ongoing |
| VERITECH PHARMACEUTICALS PRIVATE LIMITED | U24230MH2004PTC148904 | Director | 2018-07-02 | Ongoing |
| STANTECH PHARMACEUTICALS PRIVATE LIMITED | U24230MH2005PTC153516 | Director | - | 2019-07-11 |
| PHARMA SERV VENTURES PRIVATE LIMITED | U24233MH2007PTC171203 | Director | 2007-05-29 | Ongoing |
| ACUMEDICA LAB SYSTEMS PRIVATE LIMITED | U74120MH2013PTC240805 | Director | - | 2015-09-25 |
| LAVUE PHARMACEUTICALS PRIVATE LIMITED | U74900MH2009PTC196131 | Director | 2009-12-21 | Ongoing |
| NUTRAGENIX BIOLABS PRIVATE LIMITED | U74999MH2017PTC292897 | Director | 2017-03-23 | Ongoing |
| NUTRAGENIX HEALTHCARE PRIVATE LIMITED | U74999MH2017PTC292921 | Director | 2017-03-23 | Ongoing |
Other Directorships of KAUSHAL KAMLESH SHAH
Other Directorships of AMIT INDUBHUSHAN BAKSHI
Other Directorships of SAMEER ASHOK PAIGANKAR
Other Directorships of SACHIN SHAH
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Additional Director | - | 2018-09-25 |
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Director | 2018-09-25 | Ongoing |
| ERIS THERAPEUTICS LIMITED | U24230GJ2021PLC123519 | Director | 2021-06-23 | Ongoing |
| APRICA HEALTHCARE LIMITED | U24232GJ2011PLC112374 | Additional Director | - | 2018-09-26 |
| APRICA HEALTHCARE LIMITED | U24232GJ2011PLC112374 | Director | 2018-09-26 | Ongoing |
| APRICA HEALTHCARE LIMITED | U24290GJ2016PLC092903 | Additional Director | - | 2019-08-20 |
| APRICA HEALTHCARE LIMITED | U24290GJ2016PLC092903 | Director | 2019-08-20 | Ongoing |
| SWISS PARENTERALS LIMITED | U85110GJ1997PLC031645 | Additional Director | 2024-04-18 | Ongoing |
Other Directorships of MURALI VENKATA KRISHNA SISTLA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| PHARMA-SERV HEALTHCARE PRIVATE LIMITED | U24230MH2004PTC146489 | Director | 2004-05-24 | Ongoing |
| STANTECH PHARMACEUTICALS PRIVATE LIMITED | U24230MH2005PTC153516 | Director | - | 2019-07-11 |
| PHARMA SERV VENTURES PRIVATE LIMITED | U24233MH2007PTC171203 | Director | 2008-11-07 | Ongoing |
| ENALTEC LABS PRIVATE LIMITED | U73100MH2006PTC160020 | Director | - | 2008-11-11 |
| ACUMEDICA LAB SYSTEMS PRIVATE LIMITED | U74120MH2013PTC240805 | Director | - | 2015-09-25 |
| LAVUE PHARMACEUTICALS PRIVATE LIMITED | U74900MH2009PTC196131 | Director | 2009-12-21 | Ongoing |
| NUTRAGENIX BIOLABS PRIVATE LIMITED | U74999MH2017PTC292897 | Director | 2017-03-23 | Ongoing |
| NUTRAGENIX HEALTHCARE PRIVATE LIMITED | U74999MH2017PTC292921 | Director | 2017-05-11 | Ongoing |
Other Directorships of INDERJEET SINGH NEGI
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| INREAL VENTURES LLP | AAZ-7236 | Designated Partner | 2021-12-02 | Ongoing |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Director | - | 2017-02-03 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Whole-time director | 2017-02-03 | Ongoing |
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Additional Director | - | 2020-09-28 |
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Director | 2020-09-28 | Ongoing |
| ERIS THERAPEUTICS PRIVATE LIMITED | U24230GJ2009PTC057670 | Director | 2009-11-25 | Ongoing |
| ERIS THERAPEUTICS LIMITED | U24230GJ2021PLC123519 | Director | 2021-06-23 | Ongoing |
| APRICA HEALTHCARE LIMITED | U24232GJ2011PLC112374 | Additional Director | - | 2020-09-28 |
| APRICA HEALTHCARE LIMITED | U24232GJ2011PLC112374 | Director | - | 2022-06-28 |
| AMIT BAKSHI FOUNDATION | U88900GJ2024NPL150598 | Director | 2024-04-12 | Ongoing |
Other Directorships of HIMANSHU JAYANTBHAI SHAH
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Director | - | 2017-02-03 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Whole-time director | - | 2020-05-31 |
| ERIS THERAPEUTICS PRIVATE LIMITED | U24230GJ2009PTC057670 | Director | - | 2020-08-06 |
| ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED | U24233TG2008PTC060606 | Additional Director | - | 2022-03-31 |
| ERIS FORMULATIONS PRIVATE LIMITED | U24239GJ2012PTC069999 | Director | 2014-03-31 | Ongoing |
| ERIS FORMULATIONS PRIVATE LIMITED | U24239GJ2012PTC069999 | Whole-time director | - | 2014-03-31 |
| NEUCURE LIFESCIENCES PRIVATE LIMITED | U24290MP2021PTC054546 | Additional Director | - | 2023-10-03 |
Other Directorships of AKSHAY AMOL SHAH
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| M J EXPORTS PRIVATE LIMITED | U17100MH1972PTC015802 | Additional Director | - | 2020-12-18 |
| M J EXPORTS PRIVATE LIMITED | U17100MH1972PTC015802 | Director | 2020-12-18 | Ongoing |
| KAS INSTITUTE OF RESEARCH PRIVATE LIMITED | U73100PN2018PTC175349 | Additional Director | - | 2021-07-16 |
| KAS INSTITUTE OF RESEARCH PRIVATE LIMITED | U73100PN2018PTC175349 | Director | 2021-07-16 | Ongoing |
| M J INSTITUTE OF RESEARCH PRIVATE LIMITED | U99999MH1987PTC042776 | Additional Director | - | 2021-06-26 |
| M J INSTITUTE OF RESEARCH PRIVATE LIMITED | U99999MH1987PTC042776 | Director | 2021-06-26 | Ongoing |
Other Directorships of KRISHNAKUMAR VAIDYANATHAN
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ERNST & YOUNG LLP | AAB-4343 | Partner | - | 2021-01-05 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Additional Director | - | 2021-09-01 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Whole-time director | 2021-09-01 | Ongoing |
| ERIS OAKNET HEALTHCARE PRIVATE LIMITED | U74999GJ2011PTC145203 | Additional Director | - | 2022-06-02 |
| ERIS OAKNET HEALTHCARE PRIVATE LIMITED | U74999GJ2011PTC145203 | Director | 2022-05-12 | Ongoing |
| SWISS PARENTERALS LIMITED | U85110GJ1997PLC031645 | Additional Director | 2024-04-18 | Ongoing |
Other Directorships of ANIL KUMAR SHARMA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| ADROIT BIOMED LIMITED | U22100MH2009PLC197761 | Additional Director | - | 2017-09-30 |
| ADROIT BIOMED LIMITED | U22100MH2009PLC197761 | Director | 2017-09-30 | Ongoing |
| CELESTYS PHARMACEUTICALS PRIVATE LIMITED | U24233GJ2015PTC082278 | Director | 2015-02-16 | Ongoing |
| TARNEA TECHNOLOGY SOLUTIONS PRIVATE LIMITED | U72900KA2011PTC059509 | Additional Director | - | 2019-08-01 |
| QUANTUM NATURALS INDIA PRIVATE LIMITED | U85100HR2013PTC048227 | Additional Director | - | 2019-06-01 |
| LM MANUFACTURING INDIA PRIVATE LIMITED | U93000GJ2017FTC097548 | Director | - | 2023-11-06 |
Other Directorships of AMOL JASHVANT SHAH
Other Directorships of RAJENDRA RAMBHAI PATEL
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| PRARABDH HEALTHCARE LLP | AAQ-6176 | Designated Partner | 2019-09-20 | Ongoing |
| INREAL VENTURES LLP | AAZ-7236 | Designated Partner | 2021-12-02 | Ongoing |
| INREAL IINNOVATIONS LLP | ACH-5201 | Designated Partner | - | 2024-06-22 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Additional Director | - | 2012-08-16 |
| ERIS LIFESCIENCES LIMITED | L24232GJ2007PLC049867 | Director | - | 2011-08-25 |
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Additional Director | - | 2018-09-25 |
| ERIS HEALTHCARE PRIVATE LIMITED | U24211GJ2013PTC113419 | Director | - | 2020-08-06 |
| ERIS THERAPEUTICS PRIVATE LIMITED | U24230GJ2009PTC057670 | Director | - | 2020-08-06 |
| APRICA HEALTHCARE LIMITED | U24232GJ2011PLC112374 | Additional Director | - | 2020-08-06 |
| APRICA HEALTHCARE LIMITED | U24290GJ2016PLC092903 | Additional Director | - | 2018-09-28 |
| APRICA HEALTHCARE LIMITED | U24290GJ2016PLC092903 | Director | - | 2020-08-06 |
Other Directorships of RAKESH DHURIA
| Company Name | CIN | Designation | Appointment Date | Cessation |
|---|---|---|---|---|
| NOVELTY HEALTHSHINE PRIVATE LIMITED | U93090GJ2018PTC121325 | Additional Director | - | 2023-09-29 |
| NOVELTY HEALTHSHINE PRIVATE LIMITED | U93090GJ2018PTC121325 | Director | 2023-07-12 | Ongoing |
| NOVELTY HEALTHSHINE PRIVATE LIMITED | U93090GJ2018PTC121325 | Managing Director | - | 2020-01-15 |
| CIN | Company Name | Company Address |
|---|
| Charge ID | Charge Creation Date | Charge Modification Date | Charge Closure Date | Assets Under Charge | Amount | Charge Holder |
|---|---|---|---|---|---|---|
| 10426206 | 2013-03-21 | 2013-08-28 | 2022-05-11 | 17,500,000.00 | ING VYSYA BANK LIMITED | |
| 90113709 | 2006-01-16 | 2012-10-23 | 2013-10-05 | 12,500,000.00 | HDFC BANK LIMITED | |
| 100137928 | 2016-02-05 | - | 2020-01-30 | 4,500,000.00 | KOTAK MAHINDRA PRIME LIMITED | |
| 100137936 | 2016-07-31 | - | 2020-01-30 | 2,593,292.00 | KOTAK MAHINDRA PRIME LIMITED |
- Email ID
- Website
- Address
This information shows products and services that contribute highest to the company's revenue. Analysing this over a period of time can show the evolution of the company in terms of the products and services it offers.
| Financial Year | Business Activity Code | Business Activity Description | Percentage of Turnover |
|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| EQUITY AND LIABILITIES | |||||||||||||
| Shareholder's funds | |||||||||||||
| Share Capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reserves & Surplus |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Money Received Against Share Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Application Money Pending Allotment |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Liabilities | |||||||||||||
| Long-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred tax liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Long Term Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Liabilities | |||||||||||||
| Short-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade Payables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short Term Provisions |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Equity and Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASSETS | |||||||||||||
| Non-current Assets | |||||||||||||
| Fixed Assets | |||||||||||||
| Tangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital Work In Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible Assets Under Development |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax Assets (net) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Non-current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Current Assets | |||||||||||||
| Current Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Inventories |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trade receivables |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cash & Cash Equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Short-term Loans & Advances |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Current Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial information is availalbe only if it has been filed by the company. If the company has not filed its returns, financials for the defaulting period will not be available.
| 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | 2016-03-31 | 2015-03-31 | 2014-03-31 | 2013-03-31 | 2012-03-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Download Audited Financials | |||||||||||||
| REVENUE FROM OPERATIONS | |||||||||||||
| Domestic Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Supple of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Export Turnover | |||||||||||||
| Sale of Goods Manufactured |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Goods Traded |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale or Supply of Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Revenue From Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| EXPENSES | |||||||||||||
| Cost of Materials Consumed |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchases of Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in Inventories of |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finished Goods |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Work in Progress |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock in Trade |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee benefit Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Managerial Remuneration |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment to Auditors |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Insurance Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Power & Fuel |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Finance Cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation & Amortization Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Exceptional Items, Extraordinary Items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exceptional Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Extraordinary items and Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit before Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense | |||||||||||||
| Current Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred Tax |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Continuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Profit/Loss after Tax from Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tax Expense of Discontinuing Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total Profit/Loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) before Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings per Equity Share (EPS) after Extraordinary Items |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains details of cash raised by allocation of equity or debentures. All types of fund raising acitivity is listed here including funding raised through Venture Capital. Attachments would contain further details of the fund raising activity including names of the investors. This information is available only if the company has raised funds through cash allotment of equity or debentures.
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of associate companies and joint ventures as per the most recently available annual returns. This information would not be available if the company has not filed annual returns at all or it does not have any subsidiaries or joint ventures.
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains list of board resolutions reported by the company to the Registrar of Companies.
| Date of Filing | Date of Dispatch of Notice | Date of Passing Resolution | Section (Companies Act 2013) | Section (Companies Act 1956) | Subject Matter of Resolution | Resolution Agreed By | Resolution Type | Additional Documents |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This section contains auditors of a company over the years. This information is available if the company has filed their annual returns with the Registrar of Companies.
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number / Registration Number | Name of Auditor Signing Report | Membership Number of Auditor Signing Report |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Is this information out of date or is there a discrepancy with the information? Click on the Update Information button below and we will review the information.